Crossmark

The risk of transmission of the novel coronavirus (SARS-CoV-2) with human heart valve transplantation: evaluation of cardio-vascular tissues from two consecutive heart donors with asymptomatic COVID-19

Crossref DOI link: https://doi.org/10.1007/s10561-021-09913-z

Published Online: 2021-03-09

Published Print: 2021-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Jashari, R. https://orcid.org/0000-0002-0867-1998
Van Esbroeck, M.

Vanhaebost, J.

Micalessi, I.

Kerschen, A.

Mastrobuoni, S.
License Information

Text and Data Mining valid from 2021-03-09

Version of Record valid from 2021-03-09
More Information

Article History

Received: 14 October 2020

Accepted: 22 February 2021

First Online: 9 March 2021

Declarations

:

: The authors declare not having a conflict of interest. Doctor Jashari is a Director of the TE.

: Our tissue establishment is an authorized Cardiovascular Tissue Establishment in compliance with the EU and Belgian National Tissue Banking regulation. The aims of our TE were approved by the Ethical Committee of the University Hospital Saint Luc in Brussels. The donor consent was obtained in accordance with the current tissue banking regulation.

Free to read: This content has been made available to all.

Document is current

Any future updates will be listed below